BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24489833)

  • 1. Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies.
    Hua RX; Li HP; Liang YB; Zhu JH; Zhang B; Ye S; Dai QS; Xiong SQ; Gu Y; Sun XZ
    PLoS One; 2014; 9(1):e87057. PubMed ID: 24489833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian women.
    Roszak A; Lianeri M; Sowińska A; Jagodziński PP
    Mol Diagn Ther; 2013 Aug; 17(4):239-45. PubMed ID: 23633189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.
    Pabalan N; Francisco-Pabalan O; Jarjanazi H; Li H; Sung L; Ozcelik H
    Mol Biol Rep; 2012 Dec; 39(12):11061-72. PubMed ID: 23073772
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xin Y; Yang L; Su M; Cheng X; Zhu L; Liu J
    J Int Med Res; 2021 Mar; 49(3):300060521992956. PubMed ID: 33706586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population.
    Zhang Q; Li Y; Li X; Zhou W; Shi B; Chen H; Yuan W
    Mol Biol Rep; 2009 Jul; 36(6):1461-7. PubMed ID: 18716896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of an association between two BER gene polymorphisms and breast cancer risk: a meta-analysis.
    Wu B; Liu HL; Zhang S; Dong XR; Wu G
    PLoS One; 2012; 7(12):e50857. PubMed ID: 23272074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP1 Val762Ala polymorphism reduces enzymatic activity.
    Wang XG; Wang ZQ; Tong WM; Shen Y
    Biochem Biophys Res Commun; 2007 Mar; 354(1):122-6. PubMed ID: 17214964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of PARP-1 rs1136410 C>T polymorphism to the development of cancer.
    Li H; Zha Y; Du F; Liu J; Li X; Zhao X
    J Cell Mol Med; 2020 Dec; 24(24):14639-14644. PubMed ID: 33108038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP-1 Val762Ala polymorphism and risk of cancer: a meta-analysis based on 39 case-control studies.
    Qin Q; Lu J; Zhu H; Xu L; Cheng H; Zhan L; Yang X; Zhang C; Sun X
    PLoS One; 2014; 9(5):e98022. PubMed ID: 24853559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between PARP1 Single Nucleotide Polymorphism and Brain Tumors.
    Wang H; Zhang K; Qin H; Yang L; Zhang L; Cao Y
    Mol Neurobiol; 2016 May; 53(4):2083-9. PubMed ID: 25911198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.
    Wen YY; Pan XF; Loh M; Tian Z; Yang SJ; Lv SH; Huang WZ; Huang H; Xie Y; Soong R; Yang CX
    Asian Pac J Cancer Prev; 2012; 13(5):2139-44. PubMed ID: 22901183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma.
    Ye F; Cheng Q; Hu Y; Zhang J; Chen H
    PLoS One; 2012; 7(5):e37446. PubMed ID: 22624032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between PARP-1 Val762Ala polymorphism and the risk of lung cancer in a Chinese population.
    Yu P; Liu YP; Zhang JD; Qu XJ; Jin B; Zhang Y
    Tumour Biol; 2015 Jan; 36(1):177-81. PubMed ID: 25179837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1.
    Yosunkaya E; Kucukyuruk B; Onaran I; Gurel CB; Uzan M; Kanigur-Sultuybek G
    Br J Neurosurg; 2010 Oct; 24(5):561-5. PubMed ID: 20868244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi population.
    Alanazi M; Pathan AA; Abduljaleel Z; Shaik JP; Alabdulkarim HA; Semlali A; Bazzi MD; Parine NR
    PLoS One; 2013; 8(12):e85541. PubMed ID: 24392019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between RAD23B Ala249Val polymorphism and cancer susceptibility: evidence from a meta-analysis.
    Li Z; Zhang Y; Ying X; Song J; Zhang R; Li Z; Chen H; Ye P; Shen Y; Pan W; Chen Z
    PLoS One; 2014; 9(3):e91922. PubMed ID: 24643114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.
    Mao C; Qiu LX; Zhan P; Xue K; Ding H; Du FB; Li J; Chen Q
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):975-9. PubMed ID: 20012093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.
    Hu Y; Zhou M; Li K; Zhang K; Kong X; Zheng Y; Li J; Liu L
    Tumour Biol; 2014 Mar; 35(3):1715-25. PubMed ID: 24203816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis.
    Yu H; Ma H; Yin M; Wei Q
    Genet Epidemiol; 2012 Jan; 36(1):56-65. PubMed ID: 22127734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
    He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
    Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.